UniProt ID | TONSL_HUMAN | |
---|---|---|
UniProt AC | Q96HA7 | |
Protein Name | Tonsoku-like protein | |
Gene Name | TONSL | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1378 | |
Subcellular Localization | Cytoplasm. Nucleus. Mainly nuclear. Localizes to DNA damage sites, accumulates at stressed replication forks. | |
Protein Description | Component of the MMS22L-TONSL complex, a complex that stimulates the recombination-dependent repair of stalled or collapsed replication forks. The MMS22L-TONSL complex is required to maintain genome integrity during DNA replication by promoting homologous recombination-mediated repair of replication fork-associated double-strand breaks. It may act by mediating the assembly of RAD51 filaments on ssDNA. Within the complex, may act as a scaffold.. | |
Protein Sequence | MSLERELRQLSKAKAKAQRAGQRREEAALCHQLGELLAGHGRYAEALEQHWQELQLRERADDPLGCAVAHRKIGERLAEMEDYPAALQHQHQYLELAHSLRNHTELQRAWATIGRTHLDIYDHCQSRDALLQAQAAFEKSLAIVDEELEGTLAQGELNEMRTRLYLNLGLTFESLQQTALCNDYFRKSIFLAEQNHLYEDLFRARYNLGTIHWRAGQHSQAMRCLEGARECAHTMRKRFMESECCVVIAQVLQDLGDFLAAKRALKKAYRLGSQKPVQRAAICQNLQHVLAVVRLQQQLEEAEGRDPQGAMVICEQLGDLFSKAGDFPRAAEAYQKQLRFAELLDRPGAERAIIHVSLATTLGDMKDHHGAVRHYEEELRLRSGNVLEEAKTWLNIALSREEAGDAYELLAPCFQKALSCAQQAQRPQLQRQVLQHLHTVQLRLQPQEAPETETRLRELSVAEDEDEEEEAEEAAATAESEALEAGEVELSEGEDDTDGLTPQLEEDEELQGHLGRRKGSKWNRRNDMGETLLHRACIEGQLRRVQDLVRQGHPLNPRDYCGWTPLHEACNYGHLEIVRFLLDHGAAVDDPGGQGCEGITPLHDALNCGHFEVAELLLERGASVTLRTRKGLSPLETLQQWVKLYRRDLDLETRQKARAMEMLLQAAASGQDPHSSQAFHTPSSLLFDPETSPPLSPCPEPPSNSTRLPEASQAHVRVSPGQAAPAMARPRRSRHGPASSSSSSEGEDSAGPARPSQKRPRCSATAQRVAAWTPGPASNREAATASTSRAAYQAAIRGVGSAQSRLGPGPPRGHSKALAPQAALIPEEECLAGDWLELDMPLTRSRRPRPRGTGDNRRPSSTSGSDSEESRPRARAKQVRLTCMQSCSAPVNAGPSSLASEPPGSPSTPRVSEPSGDSSAAGQPLGPAPPPPIRVRVQVQDHLFLIPVPHSSDTHSVAWLAEQAAQRYYQTCGLLPRLTLRKEGALLAPQDLIPDVLQSNDEVLAEVTSWDLPPLTDRYRRACQSLGQGEHQQVLQAVELQGLGLSFSACSLALDQAQLTPLLRALKLHTALRELRLAGNRLGDKCVAELVAALGTMPSLALLDLSSNHLGPEGLRQLAMGLPGQATLQSLEELDLSMNPLGDGCGQSLASLLHACPLLSTLRLQACGFGPSFFLSHQTALGSAFQDAEHLKTLSLSYNALGAPALARTLQSLPAGTLLHLELSSVAAGKGDSDLMEPVFRYLAKEGCALAHLTLSANHLGDKAVRDLCRCLSLCPSLISLDLSANPEISCASLEELLSTLQKRPQGLSFLGLSGCAVQGPLGLGLWDKIAAQLRELQLCSRRLCAEDRDALRQLQPSRPGPGECTLDHGSKLFFRRL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MSLERELRQ ------CCHHHHHHH | 50.68 | 19413330 | |
2 | Phosphorylation | ------MSLERELRQ ------CCHHHHHHH | 50.68 | 27067055 | |
2 | O-linked_Glycosylation | ------MSLERELRQ ------CCHHHHHHH | 50.68 | 30379171 | |
187 | Ubiquitination | LCNDYFRKSIFLAEQ HCCHHHHHHHHHHHC | 37.70 | - | |
275 | Ubiquitination | AYRLGSQKPVQRAAI HHHHCCCCHHHHHHH | 49.18 | 22817900 | |
275 (in isoform 2) | Ubiquitination | - | 49.18 | 21906983 | |
275 (in isoform 1) | Ubiquitination | - | 49.18 | 21906983 | |
322 | Phosphorylation | EQLGDLFSKAGDFPR HHHHHHHHHCCCCHH | 28.97 | 24719451 | |
323 | Ubiquitination | QLGDLFSKAGDFPRA HHHHHHHHCCCCHHH | 49.40 | 21963094 | |
334 | Phosphorylation | FPRAAEAYQKQLRFA CHHHHHHHHHHHHHH | 14.03 | - | |
336 | Ubiquitination | RAAEAYQKQLRFAEL HHHHHHHHHHHHHHH | 38.33 | 29967540 | |
399 | Phosphorylation | TWLNIALSREEAGDA HHHHHHHCHHHHCCH | 28.73 | 24719451 | |
407 | Phosphorylation | REEAGDAYELLAPCF HHHHCCHHHHHHHHH | 16.32 | 27642862 | |
416 | Ubiquitination | LLAPCFQKALSCAQQ HHHHHHHHHHHHHHH | 30.92 | - | |
623 | Phosphorylation | LLLERGASVTLRTRK HHHHCCCCEEEECCC | 20.61 | 29449344 | |
625 | Phosphorylation | LERGASVTLRTRKGL HHCCCCEEEECCCCC | 14.18 | 24719451 | |
628 | Phosphorylation | GASVTLRTRKGLSPL CCCEEEECCCCCCHH | 39.58 | - | |
643 | Ubiquitination | ETLQQWVKLYRRDLD HHHHHHHHHHHCCCC | 36.52 | 29967540 | |
669 | Phosphorylation | MLLQAAASGQDPHSS HHHHHHHCCCCCCCC | 32.06 | 28348404 | |
675 | Phosphorylation | ASGQDPHSSQAFHTP HCCCCCCCCCCCCCC | 29.54 | 28348404 | |
676 | Phosphorylation | SGQDPHSSQAFHTPS CCCCCCCCCCCCCCH | 23.61 | 28348404 | |
683 | Phosphorylation | SQAFHTPSSLLFDPE CCCCCCCHHHCCCCC | 34.47 | 28348404 | |
684 | Phosphorylation | QAFHTPSSLLFDPET CCCCCCHHHCCCCCC | 30.23 | 28348404 | |
691 | Phosphorylation | SLLFDPETSPPLSPC HHCCCCCCCCCCCCC | 52.50 | 28348404 | |
692 | Phosphorylation | LLFDPETSPPLSPCP HCCCCCCCCCCCCCC | 23.90 | 28464451 | |
696 | Phosphorylation | PETSPPLSPCPEPPS CCCCCCCCCCCCCCC | 30.17 | 25137130 | |
712 | Phosphorylation | STRLPEASQAHVRVS CCCCCHHHHCCEECC | 26.66 | 22210691 | |
719 | Phosphorylation | SQAHVRVSPGQAAPA HHCCEECCCCCCCCC | 16.85 | 23401153 | |
727 | Sulfoxidation | PGQAAPAMARPRRSR CCCCCCCCCCCCCCC | 2.94 | 21406390 | |
733 | Phosphorylation | AMARPRRSRHGPASS CCCCCCCCCCCCCCC | 29.88 | 24719451 | |
739 | Phosphorylation | RSRHGPASSSSSSEG CCCCCCCCCCCCCCC | 33.61 | 20363803 | |
740 | Phosphorylation | SRHGPASSSSSSEGE CCCCCCCCCCCCCCC | 36.02 | 20363803 | |
741 | Phosphorylation | RHGPASSSSSSEGED CCCCCCCCCCCCCCC | 31.57 | 20363803 | |
742 | Phosphorylation | HGPASSSSSSEGEDS CCCCCCCCCCCCCCC | 39.57 | 20363803 | |
743 | Phosphorylation | GPASSSSSSEGEDSA CCCCCCCCCCCCCCC | 34.06 | 20363803 | |
744 | Phosphorylation | PASSSSSSEGEDSAG CCCCCCCCCCCCCCC | 52.12 | 20363803 | |
749 | Phosphorylation | SSSEGEDSAGPARPS CCCCCCCCCCCCCCC | 30.72 | 30177828 | |
756 | Phosphorylation | SAGPARPSQKRPRCS CCCCCCCCCCCCCCC | 42.66 | 30177828 | |
773 | Phosphorylation | AQRVAAWTPGPASNR HHHHHHCCCCCCCHH | 17.40 | 21815630 | |
778 | Phosphorylation | AWTPGPASNREAATA HCCCCCCCHHHHHHH | 39.28 | 24532841 | |
784 | Phosphorylation | ASNREAATASTSRAA CCHHHHHHHHHHHHH | 28.34 | 22210691 | |
788 | Phosphorylation | EAATASTSRAAYQAA HHHHHHHHHHHHHHH | 19.89 | 24532841 | |
792 | Phosphorylation | ASTSRAAYQAAIRGV HHHHHHHHHHHHHCC | 9.56 | 22210691 | |
797 | Methylation | AAYQAAIRGVGSAQS HHHHHHHHCCCCCHH | 29.08 | 30988645 | |
801 | Phosphorylation | AAIRGVGSAQSRLGP HHHHCCCCCHHHCCC | 22.26 | 22210691 | |
804 | Phosphorylation | RGVGSAQSRLGPGPP HCCCCCHHHCCCCCC | 29.23 | 22210691 | |
812 | Methylation | RLGPGPPRGHSKALA HCCCCCCCCCCCCCC | 59.60 | 115484915 | |
860 | Phosphorylation | TGDNRRPSSTSGSDS CCCCCCCCCCCCCCC | 44.42 | 23663014 | |
861 | Phosphorylation | GDNRRPSSTSGSDSE CCCCCCCCCCCCCCH | 29.31 | 23663014 | |
862 | Phosphorylation | DNRRPSSTSGSDSEE CCCCCCCCCCCCCHH | 41.25 | 23663014 | |
863 | Phosphorylation | NRRPSSTSGSDSEES CCCCCCCCCCCCHHC | 37.94 | 23663014 | |
865 | Phosphorylation | RPSSTSGSDSEESRP CCCCCCCCCCHHCCH | 37.42 | 23663014 | |
867 | Phosphorylation | SSTSGSDSEESRPRA CCCCCCCCHHCCHHH | 44.98 | 23663014 | |
870 | Phosphorylation | SGSDSEESRPRARAK CCCCCHHCCHHHHHH | 43.46 | 23663014 | |
882 | Phosphorylation | RAKQVRLTCMQSCSA HHHHHHHHHHHHCCC | 8.72 | 28450419 | |
886 | Phosphorylation | VRLTCMQSCSAPVNA HHHHHHHHCCCCCCC | 5.33 | 28450419 | |
888 | Phosphorylation | LTCMQSCSAPVNAGP HHHHHHCCCCCCCCC | 40.63 | 28450419 | |
896 | Phosphorylation | APVNAGPSSLASEPP CCCCCCCHHHCCCCC | 36.75 | 30266825 | |
897 | Phosphorylation | PVNAGPSSLASEPPG CCCCCCHHHCCCCCC | 30.96 | 30266825 | |
900 | Phosphorylation | AGPSSLASEPPGSPS CCCHHHCCCCCCCCC | 56.80 | 30266825 | |
905 | Phosphorylation | LASEPPGSPSTPRVS HCCCCCCCCCCCCCC | 22.81 | 30266825 | |
907 | Phosphorylation | SEPPGSPSTPRVSEP CCCCCCCCCCCCCCC | 53.38 | 30266825 | |
908 | Phosphorylation | EPPGSPSTPRVSEPS CCCCCCCCCCCCCCC | 20.64 | 30266825 | |
909 | Ubiquitination | PPGSPSTPRVSEPSG CCCCCCCCCCCCCCC | 38.73 | 21963094 | |
912 | Phosphorylation | SPSTPRVSEPSGDSS CCCCCCCCCCCCCCC | 45.10 | 26714015 | |
912 | O-linked_Glycosylation | SPSTPRVSEPSGDSS CCCCCCCCCCCCCCC | 45.10 | 30379171 | |
915 | Phosphorylation | TPRVSEPSGDSSAAG CCCCCCCCCCCCCCC | 51.70 | 26714015 | |
918 | Phosphorylation | VSEPSGDSSAAGQPL CCCCCCCCCCCCCCC | 25.96 | 26714015 | |
919 | Phosphorylation | SEPSGDSSAAGQPLG CCCCCCCCCCCCCCC | 27.21 | 28555341 | |
921 | Ubiquitination | PSGDSSAAGQPLGPA CCCCCCCCCCCCCCC | 21.07 | 21963094 | |
1070 | Phosphorylation | LRALKLHTALRELRL HHHHHHHHHHHHHHH | 37.51 | 24719451 | |
1198 | Phosphorylation | LKTLSLSYNALGAPA HHHHCCCHHCCCHHH | 15.11 | 20068231 | |
1245 | Ubiquitination | PVFRYLAKEGCALAH HHHHHHHHHCCHHHH | 52.63 | 21963094 | |
1263 | Ubiquitination | SANHLGDKAVRDLCR CCCHHCHHHHHHHHH | 47.16 | 29967540 | |
1273 | Phosphorylation | RDLCRCLSLCPSLIS HHHHHHHHHCCHHHC | 31.39 | 22468782 | |
1277 | Phosphorylation | RCLSLCPSLISLDLS HHHHHCCHHHCCCCC | 37.02 | 22468782 | |
1293 | Phosphorylation | NPEISCASLEELLST CCCCCHHHHHHHHHH | 40.41 | 22468782 | |
1329 | Acetylation | LGLGLWDKIAAQLRE CCCCHHHHHHHHHHH | 23.74 | 156183 | |
1341 | Phosphorylation | LRELQLCSRRLCAED HHHHHHHHHHHCCCC | 29.09 | 30576142 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TONSL_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TONSL_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TONSL_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-719, AND MASSSPECTROMETRY. |